Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Melnick, MSD
AstraZeneca
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
91 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Córdoba, Argentina
- Research Site
Santa Fe, Argentina
- Research Site
Parkville, Australia
- Research Site
Brussels, Belgium
- Research Site
Belo Horizonte, Brazil
- Research Site
Passo Fundo, Brazil
- Research Site
Salvador, Brazil
- Research Site
São José do Rio Preto, Brazil
- Research Site
Pleven, Bulgaria
- Research Site
Rousse, Bulgaria
- Research Site
Sofia, Bulgaria
- Research Site
Temuco, Chile
- Research Site
Viña del Mar, Chile
- Research Site
Beijing, China
- Research Site
Changchun, China
- Research Site
Changsha, China
- Research Site
Chengdu, China
- Research Site
Chongqing, China
- Research Site
Fuzhou, China
- Research Site
Guangzhou, China
- Research Site
Haikou, China
- Research Site
Nanning, China
- Research Site
Qingdao, China
- Research Site
Shanghai, China
- Research Site
Shenyang, China
- Research Site
Shijiazhuang, China
- Research Site
Wuhan, China
- Research Site
Xi'an, China
- Research Site
Slavonski Brod, Croatia
- Research Site
Zagreb, Croatia
- Research Site
Jihlava, Czechia
- Research Site
Pardubice, Czechia
- Research Site
Orléans, France
- Research Site
Dessau, Germany
- Research Site
Hanau, Germany
- Research Site
Heilbronn, Germany
- Research Site
Athens, Greece
- Research Site
Kowloon, Hong Kong
- Research Site
Pokfulam, Hong Kong
- Research Site
Haifa, Israel
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2012
- Primary completion
- 30 Jun 2014
- Completion
- 31 Jan 2015
- Last update posted
- 6 Sept 2017
- Registered enrollment
- 802
- Registry id
- NCT01499277
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.